334 related articles for article (PubMed ID: 15747389)
1. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes.
Kamiya H; Murakawa Y; Zhang W; Sima AA
Diabetes Metab Res Rev; 2005; 21(5):448-58. PubMed ID: 15747389
[TBL] [Abstract][Full Text] [Related]
2. C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes.
Kamiya H; Zhang W; Sima AA
Ann Neurol; 2004 Dec; 56(6):827-35. PubMed ID: 15497155
[TBL] [Abstract][Full Text] [Related]
3. C-Peptide reverses nociceptive neuropathy in type 1 diabetes.
Kamiya H; Zhang W; Ekberg K; Wahren J; Sima AA
Diabetes; 2006 Dec; 55(12):3581-7. PubMed ID: 17130507
[TBL] [Abstract][Full Text] [Related]
4. Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy.
Murakawa Y; Zhang W; Pierson CR; Brismar T; Ostenson CG; Efendic S; Sima AA
Diabetes Metab Res Rev; 2002; 18(6):473-83. PubMed ID: 12469361
[TBL] [Abstract][Full Text] [Related]
5. C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats.
Stevens MJ; Zhang W; Li F; Sima AA
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E497-505. PubMed ID: 15126237
[TBL] [Abstract][Full Text] [Related]
6. The role of impaired insulin/IGF action in primary diabetic encephalopathy.
Li ZG; Zhang W; Sima AA
Brain Res; 2005 Mar; 1037(1-2):12-24. PubMed ID: 15777748
[TBL] [Abstract][Full Text] [Related]
7. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats.
Zhang W; Kamiya H; Ekberg K; Wahren J; Sima AA
Diabetes Metab Res Rev; 2007 Jan; 23(1):63-70. PubMed ID: 16845685
[TBL] [Abstract][Full Text] [Related]
8. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
Sima AA; Zhang W; Sugimoto K; Henry D; Li Z; Wahren J; Grunberger G
Diabetologia; 2001 Jul; 44(7):889-97. PubMed ID: 11508275
[TBL] [Abstract][Full Text] [Related]
9. A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats.
Sima AA; Zhang W; Xu G; Sugimoto K; Guberski D; Yorek MA
Diabetologia; 2000 Jun; 43(6):786-93. PubMed ID: 10907124
[TBL] [Abstract][Full Text] [Related]
10. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
[TBL] [Abstract][Full Text] [Related]
11. Insulin deficiency rather than hyperglycemia accounts for impaired neurotrophic responses and nerve fiber regeneration in type 1 diabetic neuropathy.
Pierson CR; Zhang W; Murakawa Y; Sima AA
J Neuropathol Exp Neurol; 2003 Mar; 62(3):260-71. PubMed ID: 12638730
[TBL] [Abstract][Full Text] [Related]
12. Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration.
Pierson CR; Zhang W; Sima AA
J Neuropathol Exp Neurol; 2003 Jul; 62(7):765-79. PubMed ID: 12901702
[TBL] [Abstract][Full Text] [Related]
13. Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats.
Kamiya H; Zhang W; Sima AA
Diabetologia; 2006 Nov; 49(11):2763-74. PubMed ID: 17047923
[TBL] [Abstract][Full Text] [Related]
14. Skin denervation, neuropathology, and neuropathic pain in a laser-induced focal neuropathy.
Chiang HY; Chen CT; Chien HF; Hsieh ST
Neurobiol Dis; 2005 Feb; 18(1):40-53. PubMed ID: 15649695
[TBL] [Abstract][Full Text] [Related]
15. Neurotrophins and peripheral neuropathy.
Tomlinson DR; Fernyhough P; Diemel LT
Philos Trans R Soc Lond B Biol Sci; 1996 Mar; 351(1338):455-62. PubMed ID: 8730785
[TBL] [Abstract][Full Text] [Related]
16. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy.
Hellweg R; Hartung HD
J Neurosci Res; 1990 Jun; 26(2):258-67. PubMed ID: 2142224
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of endothelin B receptors and mechanical hyperalgesia in experimental chronic diabetes.
Berti-Mattera LN; Gariepy CE; Burke RM; Hall AK
Exp Neurol; 2006 Oct; 201(2):399-406. PubMed ID: 16806184
[TBL] [Abstract][Full Text] [Related]
18. Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats.
Fernyhough P; Diemel LT; Tomlinson DR
Diabetologia; 1998 Mar; 41(3):300-6. PubMed ID: 9541170
[TBL] [Abstract][Full Text] [Related]
19. Nociceptive responses and spinal plastic changes of afferent C-fibers in three neuropathic pain models induced by sciatic nerve injury in the rat.
Casals-Díaz L; Vivó M; Navarro X
Exp Neurol; 2009 May; 217(1):84-95. PubMed ID: 19416675
[TBL] [Abstract][Full Text] [Related]
20. Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy.
Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Zhang W; Sima AA
J Neuropathol Exp Neurol; 2004 May; 63(5):450-60. PubMed ID: 15198124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
